Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries

Journal of Wound Care
O GhatnekarU Persson

Abstract

This study aimed to estimate the cost-effectiveness of treating non-superficial diabetic foot ulcers with Promogran plus good wound care (GWC) compared with GWC alone in four European countries (France, Germany, Switzerland and UK). An existing Markov-based health economic model of non-superficial diabetic foot ulcers was adapted to incorporate the relative efficacy of Promogran compared with GWC alone as demonstrated in a randomised controlled trial. Treatment with Promogran was modelled for a maximum of three months. Country-specific treatment costs were used to estimate the incremental cost per ulcer-free day gained over 12 months. Some parameter assumptions were changed to assess the sensitivity of the results. Within the first three months of treatment, 26% of ulcers in the Promogran cohort healed compared with 20.7% in the GWC cohort. Over the 12 months, the average number of months spent in the healed state was 3.41 (GWC) and 3.75 (Promogran). Promogran treatment was found to be cost-saving in all four countries, using year 2000 Euro values. Promogran with GWC may be cost-effective, perhaps even cost-saving, under a wide variety of assumptions for the treatment of neuropathic foot ulcers. This study was funded by Ethicon...Continue Reading

References

Jul 1, 1995·Foot & Ankle International·J ApelqvistU Persson
Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck

❮ Previous
Next ❯

Citations

Oct 22, 2013·International Journal of Nanomedicine·L CatalfamoF S De Ponte
Oct 22, 2005·Current Medical Research and Opinion·Joshua A RayAndrew J Palmer
Jun 9, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·R Blakytny, E Jude
May 7, 2009·Cost Effectiveness and Resource Allocation : C/E·Werner A ScherbaumWilliam J Valentine
Jan 29, 2005·Diabetes Care·Ralf LobmannHendrik Lehnert
Aug 18, 2016·Journal of Cutaneous Medicine and Surgery·Mathew N Nicholas, Jensen Yeung
Nov 8, 2006·The International Journal of Lower Extremity Wounds·Paul Trueman, John Posnett
Jun 15, 2007·The International Journal of Lower Extremity Wounds·Magnus S Agren, Maria Werthén
Sep 1, 2007·Journal of Diabetes Science and Technology·Christian WeberVolker Lodwig
Aug 24, 2011·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Dietmar UlrichNorbert Pallua
Nov 15, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Mickael BassonKirsi Norrbacka
Dec 14, 2019·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Stephen C BainMatthew Capehorn
Oct 20, 2017·Advances in Skin & Wound Care·Stephanie WuTerry Treadwell
Nov 15, 2002·Journal of Wound Care·F VinS Meaume
Jan 7, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Barnaby HuntDonna Ashley
Jun 25, 2004·Journal of Wound Care·G Guarnera, A Restuccia
Dec 24, 2002·Journal of Wound Care·H Baxter
Mar 30, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Gabriela Vega-HernandezMax Schlueter
Nov 10, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Stéphane RozePierre-Yves Benhamou
Jan 11, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Matthew CapehornBarnaby Hunt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.